StreetInsider.com News Articles http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2020, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 18 Dec 2018 17:33:00 -0500 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif StreetInsider.com News Articles http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday Takeda Announces Listing of American Depositary Shares on the New York Stock Exchange http://www.streetinsider.com/Press+Releases/Takeda+Announces+Listing+of+American+Depositary+Shares+on+the+New+York+Stock+Exchange/14935837.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Takeda+Announces+Listing+of+American+Depositary+Shares+on+the+New+York+Stock+Exchange/14935837.html for the full story. http://www.streetinsider.com/Press+Releases/Takeda+Announces+Listing+of+American+Depositary+Shares+on+the+New+York+Stock+Exchange/14935837.html Tue, 18 Dec 2018 17:33:00 -0500 4502 4502 A.03052299 A.60001720 TAK TKPYY Takeda Announces Listing of American Depositary Shares on the New York Stock Exchange http://www.streetinsider.com/Press+Releases/Takeda+Announces+Listing+of+American+Depositary+Shares+on+the+New+York+Stock+Exchange/14935837.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Takeda+Announces+Listing+of+American+Depositary+Shares+on+the+New+York+Stock+Exchange/14935837.html for the full story. http://www.streetinsider.com/Press+Releases/Takeda+Announces+Listing+of+American+Depositary+Shares+on+the+New+York+Stock+Exchange/14935837.html Tue, 18 Dec 2018 17:33:00 -0500 4502 4502 A.03052299 A.60001720 TAK TKPYY Takeda Announces Listing of American Depositary Shares on the New York Stock Exchange http://www.streetinsider.com/Press+Releases/Takeda+Announces+Listing+of+American+Depositary+Shares+on+the+New+York+Stock+Exchange/14935837.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Takeda+Announces+Listing+of+American+Depositary+Shares+on+the+New+York+Stock+Exchange/14935837.html for the full story. http://www.streetinsider.com/Press+Releases/Takeda+Announces+Listing+of+American+Depositary+Shares+on+the+New+York+Stock+Exchange/14935837.html Tue, 18 Dec 2018 17:33:00 -0500 4502 4502 A.03052299 A.60001720 TAK TKPYY Takeda Announces Listing of American Depositary Shares on the New York Stock Exchange http://www.streetinsider.com/Press+Releases/Takeda+Announces+Listing+of+American+Depositary+Shares+on+the+New+York+Stock+Exchange/14935837.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Takeda+Announces+Listing+of+American+Depositary+Shares+on+the+New+York+Stock+Exchange/14935837.html for the full story. http://www.streetinsider.com/Press+Releases/Takeda+Announces+Listing+of+American+Depositary+Shares+on+the+New+York+Stock+Exchange/14935837.html Tue, 18 Dec 2018 17:33:00 -0500 4502 4502 A.03052299 A.60001720 TAK TKPYY Takeda Announces Listing of American Depositary Shares on the New York Stock Exchange http://www.streetinsider.com/Press+Releases/Takeda+Announces+Listing+of+American+Depositary+Shares+on+the+New+York+Stock+Exchange/14935837.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Takeda+Announces+Listing+of+American+Depositary+Shares+on+the+New+York+Stock+Exchange/14935837.html for the full story. http://www.streetinsider.com/Press+Releases/Takeda+Announces+Listing+of+American+Depositary+Shares+on+the+New+York+Stock+Exchange/14935837.html Tue, 18 Dec 2018 17:33:00 -0500 4502 4502 A.03052299 A.60001720 TAK TKPYY Takeda Announces Listing of American Depositary Shares on the New York Stock Exchange http://www.streetinsider.com/Press+Releases/Takeda+Announces+Listing+of+American+Depositary+Shares+on+the+New+York+Stock+Exchange/14935837.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Takeda+Announces+Listing+of+American+Depositary+Shares+on+the+New+York+Stock+Exchange/14935837.html for the full story. http://www.streetinsider.com/Press+Releases/Takeda+Announces+Listing+of+American+Depositary+Shares+on+the+New+York+Stock+Exchange/14935837.html Tue, 18 Dec 2018 17:33:00 -0500 4502 4502 A.03052299 A.60001720 TAK TKPYY Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma in Combination with AVD http://www.streetinsider.com/Press+Releases/Takeda+Receives+Positive+CHMP+Opinion+for+ADCETRIS%C2%AE+%28brentuximab+vedotin%29+for+the+Treatment+of+Adult+Patients+with+Previously+Untreated+CD30%2B+Stage+IV+Hodgkin+Lymphoma+in+Combination+with+AVD/14924907.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Takeda+Receives+Positive+CHMP+Opinion+for+ADCETRIS%C2%AE+%28brentuximab+vedotin%29+for+the+Treatment+of+Adult+Patients+with+Previously+Untreated+CD30%2B+Stage+IV+Hodgkin+Lymphoma+in+Combination+with+AVD/14924907.html for the full story. http://www.streetinsider.com/Press+Releases/Takeda+Receives+Positive+CHMP+Opinion+for+ADCETRIS%C2%AE+%28brentuximab+vedotin%29+for+the+Treatment+of+Adult+Patients+with+Previously+Untreated+CD30%2B+Stage+IV+Hodgkin+Lymphoma+in+Combination+with+AVD/14924907.html Fri, 14 Dec 2018 12:00:00 -0500 4502 4502 A.03052299 A.17150087 TKPYY Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma in Combination with AVD http://www.streetinsider.com/Press+Releases/Takeda+Receives+Positive+CHMP+Opinion+for+ADCETRIS%C2%AE+%28brentuximab+vedotin%29+for+the+Treatment+of+Adult+Patients+with+Previously+Untreated+CD30%2B+Stage+IV+Hodgkin+Lymphoma+in+Combination+with+AVD/14924907.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Takeda+Receives+Positive+CHMP+Opinion+for+ADCETRIS%C2%AE+%28brentuximab+vedotin%29+for+the+Treatment+of+Adult+Patients+with+Previously+Untreated+CD30%2B+Stage+IV+Hodgkin+Lymphoma+in+Combination+with+AVD/14924907.html for the full story. http://www.streetinsider.com/Press+Releases/Takeda+Receives+Positive+CHMP+Opinion+for+ADCETRIS%C2%AE+%28brentuximab+vedotin%29+for+the+Treatment+of+Adult+Patients+with+Previously+Untreated+CD30%2B+Stage+IV+Hodgkin+Lymphoma+in+Combination+with+AVD/14924907.html Fri, 14 Dec 2018 12:00:00 -0500 4502 4502 A.03052299 A.17150087 TKPYY Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma in Combination with AVD http://www.streetinsider.com/Press+Releases/Takeda+Receives+Positive+CHMP+Opinion+for+ADCETRIS%C2%AE+%28brentuximab+vedotin%29+for+the+Treatment+of+Adult+Patients+with+Previously+Untreated+CD30%2B+Stage+IV+Hodgkin+Lymphoma+in+Combination+with+AVD/14924907.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Takeda+Receives+Positive+CHMP+Opinion+for+ADCETRIS%C2%AE+%28brentuximab+vedotin%29+for+the+Treatment+of+Adult+Patients+with+Previously+Untreated+CD30%2B+Stage+IV+Hodgkin+Lymphoma+in+Combination+with+AVD/14924907.html for the full story. http://www.streetinsider.com/Press+Releases/Takeda+Receives+Positive+CHMP+Opinion+for+ADCETRIS%C2%AE+%28brentuximab+vedotin%29+for+the+Treatment+of+Adult+Patients+with+Previously+Untreated+CD30%2B+Stage+IV+Hodgkin+Lymphoma+in+Combination+with+AVD/14924907.html Fri, 14 Dec 2018 12:00:00 -0500 4502 4502 A.03052299 A.17150087 TKPYY Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma in Combination with AVD http://www.streetinsider.com/Press+Releases/Takeda+Receives+Positive+CHMP+Opinion+for+ADCETRIS%C2%AE+%28brentuximab+vedotin%29+for+the+Treatment+of+Adult+Patients+with+Previously+Untreated+CD30%2B+Stage+IV+Hodgkin+Lymphoma+in+Combination+with+AVD/14924907.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Takeda+Receives+Positive+CHMP+Opinion+for+ADCETRIS%C2%AE+%28brentuximab+vedotin%29+for+the+Treatment+of+Adult+Patients+with+Previously+Untreated+CD30%2B+Stage+IV+Hodgkin+Lymphoma+in+Combination+with+AVD/14924907.html for the full story. http://www.streetinsider.com/Press+Releases/Takeda+Receives+Positive+CHMP+Opinion+for+ADCETRIS%C2%AE+%28brentuximab+vedotin%29+for+the+Treatment+of+Adult+Patients+with+Previously+Untreated+CD30%2B+Stage+IV+Hodgkin+Lymphoma+in+Combination+with+AVD/14924907.html Fri, 14 Dec 2018 12:00:00 -0500 4502 4502 A.03052299 A.17150087 TKPYY Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma in Combination with AVD http://www.streetinsider.com/Press+Releases/Takeda+Receives+Positive+CHMP+Opinion+for+ADCETRIS%C2%AE+%28brentuximab+vedotin%29+for+the+Treatment+of+Adult+Patients+with+Previously+Untreated+CD30%2B+Stage+IV+Hodgkin+Lymphoma+in+Combination+with+AVD/14924907.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Takeda+Receives+Positive+CHMP+Opinion+for+ADCETRIS%C2%AE+%28brentuximab+vedotin%29+for+the+Treatment+of+Adult+Patients+with+Previously+Untreated+CD30%2B+Stage+IV+Hodgkin+Lymphoma+in+Combination+with+AVD/14924907.html for the full story. http://www.streetinsider.com/Press+Releases/Takeda+Receives+Positive+CHMP+Opinion+for+ADCETRIS%C2%AE+%28brentuximab+vedotin%29+for+the+Treatment+of+Adult+Patients+with+Previously+Untreated+CD30%2B+Stage+IV+Hodgkin+Lymphoma+in+Combination+with+AVD/14924907.html Fri, 14 Dec 2018 12:00:00 -0500 4502 4502 A.03052299 A.17150087 TKPYY Takeda and the New York Academy of Sciences Announce 2019 Innovators in Science Award Winners http://www.streetinsider.com/Press+Releases/Takeda+and+the+New+York+Academy+of+Sciences+Announce+2019+Innovators+in+Science+Award+Winners/14915010.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Takeda+and+the+New+York+Academy+of+Sciences+Announce+2019+Innovators+in+Science+Award+Winners/14915010.html for the full story. http://www.streetinsider.com/Press+Releases/Takeda+and+the+New+York+Academy+of+Sciences+Announce+2019+Innovators+in+Science+Award+Winners/14915010.html Wed, 12 Dec 2018 08:00:00 -0500 4502 4502 A.03052299 TKPYY Takeda and the New York Academy of Sciences Announce 2019 Innovators in Science Award Winners http://www.streetinsider.com/Press+Releases/Takeda+and+the+New+York+Academy+of+Sciences+Announce+2019+Innovators+in+Science+Award+Winners/14915010.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Takeda+and+the+New+York+Academy+of+Sciences+Announce+2019+Innovators+in+Science+Award+Winners/14915010.html for the full story. http://www.streetinsider.com/Press+Releases/Takeda+and+the+New+York+Academy+of+Sciences+Announce+2019+Innovators+in+Science+Award+Winners/14915010.html Wed, 12 Dec 2018 08:00:00 -0500 4502 4502 A.03052299 TKPYY Takeda and the New York Academy of Sciences Announce 2019 Innovators in Science Award Winners http://www.streetinsider.com/Press+Releases/Takeda+and+the+New+York+Academy+of+Sciences+Announce+2019+Innovators+in+Science+Award+Winners/14915010.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Takeda+and+the+New+York+Academy+of+Sciences+Announce+2019+Innovators+in+Science+Award+Winners/14915010.html for the full story. http://www.streetinsider.com/Press+Releases/Takeda+and+the+New+York+Academy+of+Sciences+Announce+2019+Innovators+in+Science+Award+Winners/14915010.html Wed, 12 Dec 2018 08:00:00 -0500 4502 4502 A.03052299 TKPYY Takeda and the New York Academy of Sciences Announce 2019 Innovators in Science Award Winners http://www.streetinsider.com/Press+Releases/Takeda+and+the+New+York+Academy+of+Sciences+Announce+2019+Innovators+in+Science+Award+Winners/14915010.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Takeda+and+the+New+York+Academy+of+Sciences+Announce+2019+Innovators+in+Science+Award+Winners/14915010.html for the full story. http://www.streetinsider.com/Press+Releases/Takeda+and+the+New+York+Academy+of+Sciences+Announce+2019+Innovators+in+Science+Award+Winners/14915010.html Wed, 12 Dec 2018 08:00:00 -0500 4502 4502 A.03052299 TKPYY Form F-6 Takeda Pharmaceutical Filed by: BANK OF NEW YORK / ADR DIVISION http://www.streetinsider.com/SEC+Filings/Form++F-6++++++++Takeda+Pharmaceutical++++++++++++++++++Filed+by%3A+BANK+OF+NEW+YORK++ADR+DIVISION/14898605.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++F-6++++++++Takeda+Pharmaceutical++++++++++++++++++Filed+by%3A+BANK+OF+NEW+YORK++ADR+DIVISION/14898605.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++F-6++++++++Takeda+Pharmaceutical++++++++++++++++++Filed+by%3A+BANK+OF+NEW+YORK++ADR+DIVISION/14898605.html Thu, 06 Dec 2018 15:22:00 -0500 4502 TKPYY Form F-6 Takeda Pharmaceutical Filed by: BANK OF NEW YORK / ADR DIVISION http://www.streetinsider.com/SEC+Filings/Form++F-6++++++++Takeda+Pharmaceutical++++++++++++++++++Filed+by%3A+BANK+OF+NEW+YORK++ADR+DIVISION/14898605.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++F-6++++++++Takeda+Pharmaceutical++++++++++++++++++Filed+by%3A+BANK+OF+NEW+YORK++ADR+DIVISION/14898605.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++F-6++++++++Takeda+Pharmaceutical++++++++++++++++++Filed+by%3A+BANK+OF+NEW+YORK++ADR+DIVISION/14898605.html Thu, 06 Dec 2018 15:22:00 -0500 4502 TKPYY Takeda Shareholders Approve Resolutions Related to the Proposed Acquisition of Shire plc http://www.streetinsider.com/Press+Releases/Takeda+Shareholders+Approve+Resolutions+Related+to+the+Proposed+Acquisition+of+Shire+plc/14892609.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Takeda+Shareholders+Approve+Resolutions+Related+to+the+Proposed+Acquisition+of+Shire+plc/14892609.html for the full story. http://www.streetinsider.com/Press+Releases/Takeda+Shareholders+Approve+Resolutions+Related+to+the+Proposed+Acquisition+of+Shire+plc/14892609.html Tue, 04 Dec 2018 22:33:00 -0500 4502 4502 A.03052299 TKPYY Takeda Shareholders Approve Resolutions Related to the Proposed Acquisition of Shire plc http://www.streetinsider.com/Press+Releases/Takeda+Shareholders+Approve+Resolutions+Related+to+the+Proposed+Acquisition+of+Shire+plc/14892609.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Takeda+Shareholders+Approve+Resolutions+Related+to+the+Proposed+Acquisition+of+Shire+plc/14892609.html for the full story. http://www.streetinsider.com/Press+Releases/Takeda+Shareholders+Approve+Resolutions+Related+to+the+Proposed+Acquisition+of+Shire+plc/14892609.html Tue, 04 Dec 2018 22:33:00 -0500 4502 4502 A.03052299 TKPYY Takeda Shareholders Approve Resolutions Related to the Proposed Acquisition of Shire plc http://www.streetinsider.com/Press+Releases/Takeda+Shareholders+Approve+Resolutions+Related+to+the+Proposed+Acquisition+of+Shire+plc/14892609.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Takeda+Shareholders+Approve+Resolutions+Related+to+the+Proposed+Acquisition+of+Shire+plc/14892609.html for the full story. http://www.streetinsider.com/Press+Releases/Takeda+Shareholders+Approve+Resolutions+Related+to+the+Proposed+Acquisition+of+Shire+plc/14892609.html Tue, 04 Dec 2018 22:33:00 -0500 4502 4502 A.03052299 TKPYY Takeda Shareholders Approve Resolutions Related to the Proposed Acquisition of Shire plc http://www.streetinsider.com/Press+Releases/Takeda+Shareholders+Approve+Resolutions+Related+to+the+Proposed+Acquisition+of+Shire+plc/14892609.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Takeda+Shareholders+Approve+Resolutions+Related+to+the+Proposed+Acquisition+of+Shire+plc/14892609.html for the full story. http://www.streetinsider.com/Press+Releases/Takeda+Shareholders+Approve+Resolutions+Related+to+the+Proposed+Acquisition+of+Shire+plc/14892609.html Tue, 04 Dec 2018 22:33:00 -0500 4502 4502 A.03052299 TKPYY Seattle Genetics and Takeda Present Positive Data from Phase 3 ECHELON-2 Clinical Trial for ADCETRIS® (Brentuximab Vedotin) in Frontline Treatment of CD30-Expressing Peripheral T-Cell Lymphomas http://www.streetinsider.com/Press+Releases/Seattle+Genetics+and+Takeda+Present+Positive+Data+from+Phase+3+ECHELON-2+Clinical+Trial+for+ADCETRIS%C2%AE+%28Brentuximab+Vedotin%29+in+Frontline+Treatment+of+CD30-Expressing+Peripheral+T-Cell+Lymphomas/14886910.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Seattle+Genetics+and+Takeda+Present+Positive+Data+from+Phase+3+ECHELON-2+Clinical+Trial+for+ADCETRIS%C2%AE+%28Brentuximab+Vedotin%29+in+Frontline+Treatment+of+CD30-Expressing+Peripheral+T-Cell+Lymphomas/14886910.html for the full story. http://www.streetinsider.com/Press+Releases/Seattle+Genetics+and+Takeda+Present+Positive+Data+from+Phase+3+ECHELON-2+Clinical+Trial+for+ADCETRIS%C2%AE+%28Brentuximab+Vedotin%29+in+Frontline+Treatment+of+CD30-Expressing+Peripheral+T-Cell+Lymphomas/14886910.html Mon, 03 Dec 2018 21:15:00 -0500 4502 A.03052299 A.17150087 A.32727947 A.33934625 SGEN TKPYY Seattle Genetics and Takeda Present Positive Data from Phase 3 ECHELON-2 Clinical Trial for ADCETRIS® (Brentuximab Vedotin) in Frontline Treatment of CD30-Expressing Peripheral T-Cell Lymphomas http://www.streetinsider.com/Press+Releases/Seattle+Genetics+and+Takeda+Present+Positive+Data+from+Phase+3+ECHELON-2+Clinical+Trial+for+ADCETRIS%C2%AE+%28Brentuximab+Vedotin%29+in+Frontline+Treatment+of+CD30-Expressing+Peripheral+T-Cell+Lymphomas/14886910.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Seattle+Genetics+and+Takeda+Present+Positive+Data+from+Phase+3+ECHELON-2+Clinical+Trial+for+ADCETRIS%C2%AE+%28Brentuximab+Vedotin%29+in+Frontline+Treatment+of+CD30-Expressing+Peripheral+T-Cell+Lymphomas/14886910.html for the full story. http://www.streetinsider.com/Press+Releases/Seattle+Genetics+and+Takeda+Present+Positive+Data+from+Phase+3+ECHELON-2+Clinical+Trial+for+ADCETRIS%C2%AE+%28Brentuximab+Vedotin%29+in+Frontline+Treatment+of+CD30-Expressing+Peripheral+T-Cell+Lymphomas/14886910.html Mon, 03 Dec 2018 21:15:00 -0500 4502 A.03052299 A.17150087 A.32727947 A.33934625 SGEN TKPYY Seattle Genetics and Takeda Present Positive Data from Phase 3 ECHELON-2 Clinical Trial for ADCETRIS® (Brentuximab Vedotin) in Frontline Treatment of CD30-Expressing Peripheral T-Cell Lymphomas http://www.streetinsider.com/Press+Releases/Seattle+Genetics+and+Takeda+Present+Positive+Data+from+Phase+3+ECHELON-2+Clinical+Trial+for+ADCETRIS%C2%AE+%28Brentuximab+Vedotin%29+in+Frontline+Treatment+of+CD30-Expressing+Peripheral+T-Cell+Lymphomas/14886910.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Seattle+Genetics+and+Takeda+Present+Positive+Data+from+Phase+3+ECHELON-2+Clinical+Trial+for+ADCETRIS%C2%AE+%28Brentuximab+Vedotin%29+in+Frontline+Treatment+of+CD30-Expressing+Peripheral+T-Cell+Lymphomas/14886910.html for the full story. http://www.streetinsider.com/Press+Releases/Seattle+Genetics+and+Takeda+Present+Positive+Data+from+Phase+3+ECHELON-2+Clinical+Trial+for+ADCETRIS%C2%AE+%28Brentuximab+Vedotin%29+in+Frontline+Treatment+of+CD30-Expressing+Peripheral+T-Cell+Lymphomas/14886910.html Mon, 03 Dec 2018 21:15:00 -0500 4502 A.03052299 A.17150087 A.32727947 A.33934625 SGEN TKPYY Seattle Genetics and Takeda Present Positive Data from Phase 3 ECHELON-2 Clinical Trial for ADCETRIS® (Brentuximab Vedotin) in Frontline Treatment of CD30-Expressing Peripheral T-Cell Lymphomas http://www.streetinsider.com/Press+Releases/Seattle+Genetics+and+Takeda+Present+Positive+Data+from+Phase+3+ECHELON-2+Clinical+Trial+for+ADCETRIS%C2%AE+%28Brentuximab+Vedotin%29+in+Frontline+Treatment+of+CD30-Expressing+Peripheral+T-Cell+Lymphomas/14886910.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Seattle+Genetics+and+Takeda+Present+Positive+Data+from+Phase+3+ECHELON-2+Clinical+Trial+for+ADCETRIS%C2%AE+%28Brentuximab+Vedotin%29+in+Frontline+Treatment+of+CD30-Expressing+Peripheral+T-Cell+Lymphomas/14886910.html for the full story. http://www.streetinsider.com/Press+Releases/Seattle+Genetics+and+Takeda+Present+Positive+Data+from+Phase+3+ECHELON-2+Clinical+Trial+for+ADCETRIS%C2%AE+%28Brentuximab+Vedotin%29+in+Frontline+Treatment+of+CD30-Expressing+Peripheral+T-Cell+Lymphomas/14886910.html Mon, 03 Dec 2018 21:15:00 -0500 4502 A.03052299 A.17150087 A.32727947 A.33934625 SGEN TKPYY